CDK8-Novel Therapeutic Opportunities
Improvements in cancer therapy frequently stem from the development of new small-molecule inhibitors, paralleled by the identification of biomarkers that can predict the treatment response. Recent evidence supports the idea that cyclin-dependent kinase 8 (CDK8) may represent a potential drug target...
Saved in:
Main Authors: | Ingeborg Menzl (Author), Agnieszka Witalisz-Siepracka (Author), Veronika Sexl (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2019-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CDK4/6 and MAPK-Crosstalk as Opportunity for Cancer Treatment
by: Lisa Scheiblecker, et al.
Published: (2020) -
Unveiling the impact of CDK8 on tumor progression: mechanisms and therapeutic strategies
by: Xiaomin Yin, et al.
Published: (2024) -
Discovery of novel and potent CDK8 inhibitors for the treatment of acute myeloid leukaemia
by: Zhuoying Chen, et al.
Published: (2024) -
Cdk8 attenuates lipogenesis by inhibiting SREBP-dependent transcription in Drosophila
by: Xiao Li, et al.
Published: (2022) -
Novel CDK4/6 lnhibitor, WXJ-8 -Exerts Anti-effects Through Cell Cycle in Breast Cancer
by: Jing Ji, et al.
Published: (2023)